S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
State of the Union: Biden sees economic glow, GOP sees gloom
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Tesla hikes price of Model Y after US alters tax credit rule
Disney World unions vote down offer covering 45,000 workers
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Route to Super Bowl dangerous for Mexico's avocado haulers
Iraqi currency crash halts after meeting with U.S. official
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
How will EU ban and West's price cap on Russian diesel work?
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
State of the Union: Biden sees economic glow, GOP sees gloom
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Tesla hikes price of Model Y after US alters tax credit rule
Disney World unions vote down offer covering 45,000 workers
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Route to Super Bowl dangerous for Mexico's avocado haulers
Iraqi currency crash halts after meeting with U.S. official
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
How will EU ban and West's price cap on Russian diesel work?
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
State of the Union: Biden sees economic glow, GOP sees gloom
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Tesla hikes price of Model Y after US alters tax credit rule
Disney World unions vote down offer covering 45,000 workers
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Route to Super Bowl dangerous for Mexico's avocado haulers
Iraqi currency crash halts after meeting with U.S. official
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
How will EU ban and West's price cap on Russian diesel work?
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
State of the Union: Biden sees economic glow, GOP sees gloom
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Tesla hikes price of Model Y after US alters tax credit rule
Disney World unions vote down offer covering 45,000 workers
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Route to Super Bowl dangerous for Mexico's avocado haulers
Iraqi currency crash halts after meeting with U.S. official
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
How will EU ban and West's price cap on Russian diesel work?
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
NASDAQ:CYRX

Cryoport - CYRX Stock Forecast, Price & News

$25.24
-0.62 (-2.40%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
$24.98
$26.01
50-Day Range
$15.97
$25.86
52-Week Range
$15.63
$45.36
Volume
394,049 shs
Average Volume
469,868 shs
Market Capitalization
$1.24 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$40.50

Cryoport MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
60.5% Upside
$40.50 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.64mentions of Cryoport in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$142,318 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.89) to ($0.63) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.10 out of 5 stars

Transportation Sector

69th out of 121 stocks

Pharmaceutical Preparations Industry

248th out of 501 stocks

CYRX stock logo

About Cryoport (NASDAQ:CYRX) Stock

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.

Receive CYRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryoport and its competitors with MarketBeat's FREE daily newsletter.

CYRX Stock News Headlines

When Will Cryoport, Inc. (NASDAQ:CYRX) Become Profitable?
Cryoport (NASDAQ:CYRX) Shares Down 6.2%
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
Madrigal Pharmaceuticals: Upcoming Windfall Profits
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
5 Analysts Have This to Say About CryoPort
Expert Ratings for CryoPort
Cryoport Third Quarter 2022 Earnings: Misses Expectations
Cryoport Reports Results for the Third Quarter 2022
Notable Friday Option Activity: AMD, CYRX, SQ
See More Headlines
Receive CYRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryoport and its competitors with MarketBeat's FREE daily newsletter.

CYRX Company Calendar

Last Earnings
11/04/2021
Today
2/05/2023
Next Earnings (Estimated)
2/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CYRX
Employees
791
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$40.50
High Stock Price Forecast
$67.00
Low Stock Price Forecast
$28.00
Forecasted Upside/Downside
+60.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-275,530,000.00
Net Margins
-123.41%
Pretax Margin
-123.46%

Debt

Sales & Book Value

Annual Sales
$222.61 million
Book Value
$13.64 per share

Miscellaneous

Free Float
44,247,000
Market Cap
$1.24 billion
Optionable
Optionable
Beta
1.32

Key Executives

  • Jerrell W. SheltonJerrell W. Shelton
    Chairman, President & Chief Executive Officer
  • Robert S. StefanovichRobert S. Stefanovich
    Chief Financial Officer, Secretary & Treasurer
  • Mark W. SawickiMark W. Sawicki
    Chief Scientific Officer
  • Thomas J. Heinzen
    Vice President-Corporate Development













CYRX Stock - Frequently Asked Questions

Should I buy or sell Cryoport stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cryoport in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CYRX shares.
View CYRX analyst ratings
or view top-rated stocks.

What is Cryoport's stock price forecast for 2023?

4 Wall Street analysts have issued 1 year price targets for Cryoport's stock. Their CYRX share price forecasts range from $28.00 to $67.00. On average, they expect the company's stock price to reach $40.50 in the next year. This suggests a possible upside of 60.5% from the stock's current price.
View analysts price targets for CYRX
or view top-rated stocks among Wall Street analysts.

How have CYRX shares performed in 2023?

Cryoport's stock was trading at $17.35 at the start of the year. Since then, CYRX shares have increased by 45.5% and is now trading at $25.24.
View the best growth stocks for 2023 here
.

When is Cryoport's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our CYRX earnings forecast
.

How were Cryoport's earnings last quarter?

Cryoport, Inc. (NASDAQ:CYRX) announced its quarterly earnings results on Thursday, November, 4th. The consumer goods maker reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.15) by $0.03. The consumer goods maker had revenue of $56.69 million for the quarter, compared to analyst estimates of $54.44 million. Cryoport had a negative net margin of 123.41% and a negative trailing twelve-month return on equity of 14.84%. The company's revenue was up 407.5% on a year-over-year basis. During the same period in the previous year, the company posted ($0.29) earnings per share.

What guidance has Cryoport issued on next quarter's earnings?

Cryoport issued an update on its FY 2022 earnings guidance on Thursday, November, 10th. The company provided EPS guidance of for the period. The company issued revenue guidance of $232.00 million-$238.00 million, compared to the consensus revenue estimate of $260.68 million.

What other stocks do shareholders of Cryoport own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cryoport investors own include Gilead Sciences (GILD), Advanced Micro Devices (AMD), Micron Technology (MU), NVIDIA (NVDA), Taiwan Semiconductor Manufacturing (TSM), Amarin (AMRN), QUALCOMM (QCOM), Enterprise Products Partners (EPD), Pfizer (PFE) and Block (SQ).

What is Cryoport's stock symbol?

Cryoport trades on the NASDAQ under the ticker symbol "CYRX."

Who are Cryoport's major shareholders?

Cryoport's stock is owned by a variety of retail and institutional investors. Top institutional investors include New York State Common Retirement Fund (2.43%), Redwood Investments LLC (1.04%), Moody Aldrich Partners LLC (0.21%), Essex Investment Management Co. LLC (0.13%), DNB Asset Management AS (0.12%) and Conestoga Capital Advisors LLC (0.11%). Insiders that own company stock include Daniel M Hancock, Daniel M Hancock, Edward J Zecchini, Freeze Parent LP Blackstone, Jerrell Shelton, Mark W Sawicki, Michael R Egeck, Richard J Berman, Robert J Hariri and Robert Stefanovich.
View institutional ownership trends
.

How do I buy shares of Cryoport?

Shares of CYRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cryoport's stock price today?

One share of CYRX stock can currently be purchased for approximately $25.24.

How much money does Cryoport make?

Cryoport (NASDAQ:CYRX) has a market capitalization of $1.24 billion and generates $222.61 million in revenue each year. The consumer goods maker earns $-275,530,000.00 in net income (profit) each year or ($6.15) on an earnings per share basis.

How many employees does Cryoport have?

The company employs 791 workers across the globe.

How can I contact Cryoport?

Cryoport's mailing address is 112 Westwood Place Suite 350, Brentwood TN, 37027. The official website for the company is www.cryoport.com. The consumer goods maker can be reached via phone at (949) 470-2300, via email at tfromer@kcsa.com, or via fax at 949-470-2306.

This page (NASDAQ:CYRX) was last updated on 2/5/2023 by MarketBeat.com Staff